scholarly journals Heart Rate Recovery After Exercise Is a Predictor of Silent Myocardial Ischemia in Patients With Type 2 Diabetes

Diabetes Care ◽  
2011 ◽  
Vol 34 (3) ◽  
pp. 724-726 ◽  
Author(s):  
T. Yamada ◽  
T. Yoshitama ◽  
K. Makino ◽  
T. Lee ◽  
F. Saeki
Keyword(s):  
Type 2 Diabetes ◽  
Heart Rate ◽  
Myocardial Ischemia ◽  
Heart Rate Recovery ◽  
Silent Myocardial Ischemia

Silent Myocardial Ischemia in Middle-Aged Asymptomatic Patients With Type 2 Diabetes in Turkish Population

Angiology ◽  
2007 ◽  
Vol 58 (5) ◽  
pp. 535-542
Author(s):  
Betul Ugur-Altun ◽  
Armagan Altun ◽  
Sibel Guldiken ◽  
Ersan Tatli ◽  
Mujdat Kara ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Myocardial Ischemia ◽  
Turkish Population ◽  
Silent Myocardial Ischemia ◽  
Middle Aged ◽  
Asymptomatic Patients

scholarly journals Asymptomatic cardiovascular manifestations in diabetes mellitus: Left ventricular diastolic dysfunction and silent myocardial ischemia

2011 ◽  
Vol 139 (9-10) ◽  
pp. 599-604
Author(s):  
Jelena Seferovic-Mitrovic ◽  
Nebojsa Lalic ◽  
Bosiljka Vujisic-Tesic ◽  
Katarina Lalic ◽  
Aleksandra Jotic ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Myocardial Ischemia ◽  
Diastolic Dysfunction ◽  
Tissue Doppler ◽  
Left Ventricular Diastolic Dysfunction ◽  
Left Ventricular ◽  
Silent Myocardial Ischemia ◽  
Ventricular Diastolic Dysfunction ◽  
Patients With Diabetes

Introduction. Several cardiovascular manifestations in patients with diabetes may be asymptomatic. Left ventricular diastolic dysfunction (LVDD) is considered to be the earliest metabolic myocardial lesion in these patients, and can be diagnosed with tissue Doppler echocardiography. Silent myocardial ischemia (SMI) is a characteristic and frequently described form of ischemic heart disease in patients with diabetes. Objective. The aim of the study was to assess the prevalence of LVDD and SMI in patients with type 2 diabetes, as well as to compare demographic, clinical, and metabolic data among defined groups (patients with LVDD, patients with SMI and patients with type 2 diabetes, without LVDD and SMI). Methods. We investigated 104 type 2 diabetic patients (mean age 55.4?9.1 years, 64.4% males) with normal blood pressure, prehypertension and arterial hypertension stage I. Study design included basic laboratory assessment and cardiological workup (transthoracic echocardiography and tissue Doppler, as well as the exercise stress echocardiography). Results. LVDD was diagnosed in twelve patients (11.5%), while SMI was revealed in six patients (5.8%). Less patients with LVDD were using metformin, in comparison to other two groups (?2 =12.152; p=0.002). Values of HDL cholesterol (F=4.515; p=0.013) and apolipoprotein A1 (F=5.128; p= 0.008) were significantly higher in patients with LVDD. Conclusion. The study confirmed asymptomatic cardiovascular complications in 17.3% patients with type 2 diabetes.

scholarly journals Prevalence and RIsk factors for Silent Myocardial ischemia (PRISM): A clinico observational study in patients of type 2 diabetes

2019 ◽  
Vol 71 (5) ◽  
pp. 400-405 ◽  
Author(s):  
D.S. Prasad ◽  
Zubair Kabir ◽  
K. Revathi Devi ◽  
Pearline Suganthy Peter ◽  
B.C. Das
Keyword(s):  
Risk Factors ◽  
Type 2 Diabetes ◽  
Myocardial Ischemia ◽  
Observational Study ◽  
Silent Myocardial Ischemia
Sign in / Sign up

Export Citation Format

Share Document